Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 175
About this episode
Dr. Jason Yerke discusses terlipressin administration strategies in the context of hepatorenal syndrome and acute kidney injury.
Dr. Jason Yerke summarizes current evidence from clinical trials and comparative studies evaluating terlipressin continuous infusion versus intermittent bolus dosing strategies, with a focus on efficacy, safety, and operational considerations. Read the full-text manuscript: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70084 .
More episodes of ACCP JOURNALS
- Navigating Cardiotoxicity in Modern Cancer Therapy - Ep 181
- High-Value Interventions Primary Care Practices Might Be Overlooking: Clinical Pharmacy Services – Ep 180
- Enhancing Pharmacotherapy Through Artificial Intelligence: From Prediction Models to Practice – Ep 179
- A Medical Writing Rotation: Flipping the Odds on Resident Scholarship - Ep 178
- Thinking Like Tree Farmers Not Muffin Makers: Why We Need a Competency-based Framework at all Levels of Professional Education - Ep 177
- An Aging HIV+ Population: The Urgent Need (and Opportunities) for HIV-trained Pharmacists - Ep 176
Explore listener stats, chart rankings, contacts and more on the ACCP JOURNALS podcast page.